These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1920963)

  • 1. Magnetic resonance imaging in diagnosis and follow-up of minimal thyroid ophthalmopathy.
    Matsuo H; Motomura M; Takeo G; Yoshimura T; Tsujihata M; Nagataki S
    Jpn J Med; 1991; 30(3):229-32. PubMed ID: 1920963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
    Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
    Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.
    Ohnishi T; Noguchi S; Murakami N; Tajiri J; Harao M; Kawamoto H; Hoshi H; Jinnouchi S; Futami S; Nagamachi S
    Radiology; 1994 Mar; 190(3):857-62. PubMed ID: 8115640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Hiromatsu Y; Tanaka K; Sato M; Kuroki T; Nonaka K; Kojima K; Nishimura H; Nishida H; Kaise N
    Endocr J; 1993 Feb; 40(1):63-72. PubMed ID: 7951498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.
    Nakahara H; Noguchi S; Murakami N; Morita M; Tamaru M; Ohnishi T; Hoshi H; Jinnouchi S; Nagamachi S; Futami S
    Radiology; 1995 Sep; 196(3):857-62. PubMed ID: 7644656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' disease of the orbit.
    Weber AL; Dallow RL; Sabates NR
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI measurements of orbital tissues in dysthyroid ophthalmopathy.
    Nishida Y; Tian S; Isberg B; Tallstedt L; Lennerstrand G
    Graefes Arch Clin Exp Ophthalmol; 2001 Nov; 239(11):824-31. PubMed ID: 11789862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
    Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L
    J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior oblique muscle involvement in thyroid ophthalmopathy.
    Thacker NM; Velez FG; Demer JL; Rosenbaum AL
    J AAPOS; 2005 Apr; 9(2):174-8. PubMed ID: 15838447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation].
    Hosten N; Schörner W; Lietz A; Wenzel KW
    Rofo; 1992 Sep; 157(3):210-4. PubMed ID: 1391813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated inferior rectus muscle palsy resulting from a nuclear third nerve lesion as the initial manifestation of multiple sclerosis.
    Lee AG; Tang RA; Wong GG; Schiffman JS; Singh S
    J Neuroophthalmol; 2000 Dec; 20(4):246-7. PubMed ID: 11130749
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-eye muscle antibodies and hypothyroid Graves' disease: a case report.
    Hiromatsu Y; Sato M; Tanaka K; Nonaka K; Kojima K; Sato K; Kurose S; Hoshino T; Nakashima A
    Endocrinol Jpn; 1992 Dec; 39(6):593-600. PubMed ID: 1363467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy.
    Nishida Y; Tian S; Isberg B; Hayashi O; Tallstedt L; Lennerstrand G
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):515-20. PubMed ID: 12136278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
    Utech CI; Khatibnia U; Winter PF; Wulle KG
    Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction for effectiveness of steroid pulse therapy by MRI in Graves' ophthalmopathy].
    Sato M; Hiromatsu Y; Tanaka K; Nonaka K; Kojima K; Nishimura H; Nishida H
    Nihon Naibunpi Gakkai Zasshi; 1992 Mar; 68(3):143-53. PubMed ID: 1582520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.
    Villadolid MC; Yokoyama N; Izumi M; Nishikawa T; Kimura H; Ashizawa K; Kiriyama T; Uetani M; Nagataki S
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome.
    Hart RH; Kendall-Taylor P; Crombie A; Perros P
    J Ocul Pharmacol Ther; 2005 Aug; 21(4):328-36. PubMed ID: 16117697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy.
    Kauppinen-Mäkelin R; Karma A; Leinonen E; Löyttyniemi E; Salonen O; Sane T; Setälä K; Viikari J; Heufelder A; Välimäki M
    Acta Ophthalmol Scand; 2002 Jun; 80(3):316-21. PubMed ID: 12059873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
    Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure eye muscle involvement in endocrine orbitopathy.
    Gerlach M; Ferbert A
    Eur Neurol; 2008; 60(2):67-72. PubMed ID: 18480610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.